Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks
在检测治疗策略中,多替拉韦/拉米夫定可维持病毒抑制长达 48 周
期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofad101
Rolle, Charlotte-Paige; Berhe, Mezgebe; Singh, Tulika; Ortiz, Roberto; Wurapa, Anson; Ramgopal, Moti; Jayaweera, Dushyantha T; Leone, Peter A; Matthews, Jessica E; Cupo, Michael; Underwood, Mark R; Angelis, Konstantinos; Wynne, Brian R; Merrill, Deanna; Nguyen, Christopher; van Wyk, Jean; Zolopa, Andrew R